Here are 14 key notes on orthopedic and spine device companies from the past week.
Medtronic PLC reportedly informed investors it's close to settling lawsuits pertaining to its bone morphogenetic protein product Infuse.
At its national sales meeting, ChoiceSpine launched its new biologics portfolio.
DePuy Synthes launched its VIPER and EXPEDIUM Fenestrated Screw Systems in the U.S.
Spine Wave completed the limited market release of its Leva AF Interbody Device.
K2M received FDA clearance for its Capri Small 3D Static Corpectomy System, a first-to-market 3D-printed corpectomy cage.
The FDA cleared Spineology's Rampart One Anterior Lumbar Interbody Fusion System.
Stryker was named the 15th best place for millennials to work on FORTUNE's 100 Best Workplaces for Millennials.
Intellirod Spine secured over $1 million in equity financing from new and existing investors led by the OhioHealth Innovation Development Fund and Queen City Angel First Fund V.
Smith & Nephew added total joint replacements to the Navio handheld robotic-assisted technology platform.
Zimmer Biomet unveiled its X-PSI Knee System.
InVivo Therapeutics enrolled the 17th patient in its INSPIRE Study, testing the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.
Colorado Springs, Colo.-based UCHealth Memorial Hospital joined InVivo Therapeutics' INSPIRE study as a clinical site.
Conventus Orthopaedics appointed Matthew Jewett CEO.
Jack Farr, MD, of Indianapolis-based OrthoIndy, performed the state's first meniscus replacement with Active Implants' NUsurface Meniscus Implant.